April 8, 2010 — Most children prescribed second-generation antipsychotic (SGA) drug therapy do not undergo
recommended blood glucose and lipid screening tests, according to results of a retrospective, new-user cohort study
published in the April issue of the Archives of Pediatrics and Adolescent Medicine.
“The findings in children are particularly noteworthy to clinicians,” first author Elaine H. Morrato, DrPH, MPH, of
University of Colorado at Denver in Aurora, told Medscape Psychiatry.